An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity

An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity

Abstract Background Migraine is a highly prevalent neurological disease with a substantial societal burden due to lost productivity. From a societal perspective, we assessed the cost-effectiveness of eptinezumab for the preventive treatment of migraine. Methods An individual patient simulation of di...

Full description

Bibliographic Details
Main Authors: Edward Griffin, Gawain Shirley, Xin Ying Lee, Susanne F. Awad, Alok Tyagi, Peter J. Goadsby
Format: Article
Language:English
Published: BMC 2024-04-01
Series:The Journal of Headache and Pain
Subjects:
Eptinezumab
Anti-CGRP mAbs
Migraine
Cost-effectiveness
Healthcare costs
Natural history
Online Access:https://doi.org/10.1186/s10194-024-01749-8

Internet

https://doi.org/10.1186/s10194-024-01749-8

Similar Items